Following the successful export shipments in the first quarter, VB Pharma Corp continues to affirm its production capacity and reputation in the international market when successfully opening the export in the second quarter of 2025.

The new order shows the trust of partners in the product quality as well as the professional services provided by VB Pharma Corp.


Not only is it the result of serious investment in the production line and quality control, this success also comes from the efforts of the entire staff. With a sustainable development strategy and market expansion orientation, VB Pharma Corp is gradually contributing to enhancing the value of the veterinary pharmaceutical industry.
